ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,355Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 670

$1.23M Total Retail Price of All Prescriptions

Rank: 12 out of 670

547 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 547 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

29% of this provider’s 547 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 25,047 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

52 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
HYDROCODONE-ACETAMINOPHEN 1,227 1,159 S3 1 1
FUROSEMIDE 1,145 1,086 2 6
LEVOTHYROXINE SODIUM 928 884 3 2
WARFARIN SODIUM 853 791 4 13
METOPROLOL TARTRATE 849 811 5 9
CITALOPRAM HBR 705 631 6 20
GABAPENTIN 674 587 7 11
LISINOPRIL 641 596 8 3
SIMVASTATIN 602 524 9 4
OMEPRAZOLE 575 495 10 5
POTASSIUM CHLORIDE 544 535 11 16
RISPERIDONE 541 430 12 80
MIRTAZAPINE 526 498 13 59
AMLODIPINE BESYLATE 485 438 14 7
TRAZODONE HCL 434 360 15 39
DONEPEZIL HCL 377 377 16 31
TRAMADOL HCL 362 338 17 21
SERTRALINE HCL 362 314 17 22
NAMENDA 317 296 19 54
IPRATROPIUM-ALBUTEROL 277 263 20 136
PREDNISONE 260 252 21 40
LANTUS 248 218 22 58
RANITIDINE HCL 239 195 23 25
CARBIDOPA-LEVODOPA 235 224 24 101
AZITHROMYCIN 234 202 25 35
DIGOXIN 233 221 26 46
METFORMIN HCL 224 206 27 8
CEFUROXIME 220 206 28 121
OXYCODONE-ACETAMINOPHEN 212 152 S2 29 77
PROMETHAZINE HCL 193 157 R 30 106
CLONIDINE HCL 189 155 31 62
METOPROLOL SUCCINATE 184 173 32 12
QUETIAPINE FUMARATE 180 142 33 84
NITROFURANTOIN MONO-MACRO 176 168 34 219
DIVALPROEX SODIUM 164 126 35 95
KLOR-CON M10 162 150 36 112
NOVOLOG 162 142 36 151
CLOPIDOGREL 160 142 38 24
CIPROFLOXACIN HCL 159 149 39 60
AMOXICILLIN 156 145 40 91
TAMSULOSIN HCL 155 152 41 30
METOCLOPRAMIDE HCL 154 131 42 117
CARVEDILOL 150 143 43 29
ATENOLOL 147 133 44 17
ISOSORBIDE MONONITRATE ER 138 138 45 45
SINGULAIR 135 113 46 56
PLAVIX 132 122 47 34
HYDROCHLOROTHIAZIDE 127 127 48 10
AVELOX 125 115 49 269
ALBUTEROL SULFATE 123 106 50 133
MORPHINE SULFATE ER 123 102 S2 50 104
LACTULOSE 120 101 52 107
OXYBUTYNIN CHLORIDE 117 109 53 150
LOSARTAN POTASSIUM 117 113 53 26
IBUPROFEN 114 45 55 50
BACLOFEN 113 78 56 129
OXYBUTYNIN CHLORIDE ER 111 73 57 148
GLIPIZIDE 110 108 58 67
PHENYTOIN SODIUM EXTENDED 109 97 59 135
FLUOXETINE HCL 105 78 60 55
ALLOPURINOL 102 102 61 38
PAROXETINE HCL 100 80 62 52
LYRICA 98 97 63 65
CYMBALTA 98 80 63 36
DILTIAZEM 24HR CD 98 97 63 109
AMIODARONE HCL 97 94 66 222
SODIUM CHLORIDE 95 91 67 170
ROPINIROLE HCL 95 78 67 75
SEROQUEL 93 66 69 182
DOXYCYCLINE HYCLATE 93 79 69 132
SULFAMETHOXAZOLE-TRIMETHOPRIM 92 83 71 93
ATORVASTATIN CALCIUM 92 82 71 15
OLANZAPINE 90 75 73 143
FAMOTIDINE 89 76 74 99
LEVETIRACETAM 88 76 75 152
HYDRALAZINE HCL 88 72 75 147
OXYCODONE HCL-ACETAMINOPHEN 87 42 S2 77 71
CEFTRIAXONE 86 80 78 180
LEVOFLOXACIN 84 71 79 88
CYCLOBENZAPRINE HCL 84 49 R 79 61
KLOR-CON M20 83 81 81 57
OXCARBAZEPINE 82 0 82 256
POLYETHYLENE GLYCOL 3350 82 74 82 79
MIDODRINE HCL 82 82 82 324
TRAVATAN Z 81 78 85 272
VANCOMYCIN HCL 77 74 86 231
RENVELA 77 56 86 298
EXELON 76 76 88 128
JANUVIA 75 73 89 53
PRAVASTATIN SODIUM 72 70 90 19
DIOVAN 72 72 90 48
LEVEMIR 72 72 90 196
FENTANYL 71 58 S2 93 76
MELOXICAM 71 64 93 33
MEGESTROL ACETATE 70 60 R 95 202
VENLAFAXINE HCL ER 70 69 95 97
CEPHALEXIN 70 66 95 102
ALENDRONATE SODIUM 70 60 95 43
ISOSORBIDE DINITRATE 68 64 99 234
FINASTERIDE 68 68 99 118
OXYCODONE HCL 66 19 S2 101 72
GLIMEPIRIDE 65 60 102 32
MORPHINE SULFATE 64 52 S2 103 228
NITROGLYCERIN PATCH 60 60 104 149
SPIRONOLACTONE 58 56 105 82
HYDROXYZINE HCL 58 11 R 105 205
LIDODERM 58 57 105 215
NYSTATIN 57 52 108 139
DILTIAZEM HCL 57 57 108 204
SPIRIVA 56 47 110 51
ESCITALOPRAM OXALATE 55 52 111 78
FLUTICASONE PROPIONATE 55 46 111 37
RESTASIS 55 45 111 288
HUMALOG 55 43 111 197
NOVOLIN N 53 53 115 238
MONTELUKAST SODIUM 53 42 115 96
ENDOCET 53 39 S2 115 146
DILANTIN 52 52 118 302
TRICOR 52 23 118 83
CLOTRIMAZOLE 52 50 118 361
MECLIZINE HCL 52 52 118 114
NIFEDIPINE ER 52 34 118 145
GALANTAMINE HBR 51 51 123 365
LEXAPRO 51 46 123 231
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 20, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.